Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …

The prevalence of diabetes mellitus will likely increase globally from 371 million individuals
in 2013 to 552 million individuals in 2030. This epidemic is mainly attributable to type 2 …

Executive summary Despite the improvements in outcomes for cardiovascular disease
(CVD) over the last 20 years, it remains the major cause of morbidity and mortality in the …

Background—The prevalence of smoking in diabetic patients remains high, and reliable
quantification of the excess mortality and morbidity risks associated with smoking is …

Background Other than glycemic control, there are no treatments for diabetic neuropathy.
Thus, identifying potentially modifiable risk factors for neuropathy is crucial. We studied risk …

Background Clinical guidelines differ regarding their recommended blood glucose targets
for patients with type 1 diabetes and recent studies on patients with type 2 diabetes suggest …

Diabetes mellitus is associated with cognitive dysfunction and abnormalities that can be
seen with brain imaging. Recent studies provide important new insights into the nature and …

Background Poor glycaemic control is associated with microvascular and macrovascular
complications in type 1 diabetes, but whether glycaemic control is associated with heart …

Cardiovascular disease (CVD) is highly prevalent in patients with type 1 diabetes (T1D) and
a major cause of mortality. CVD arises earlier in life in T1D patients and is responsible for a …